Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Soluble Fms-like Tyrosine kinase-1 (sFlt-1)
100%
Preeclampsia
100%
Plasma Proteomics
100%
Maternal Plasma
100%
Long-term Alterations
100%
Cardiovascular Disease
33%
Ingenuity Pathway Analysis
33%
Metabolic Disease
33%
Maternal Health
33%
Adverse Outcomes
16%
Preventive Strategies
16%
Overexpression
16%
Adenovirus
16%
Inflammatory Response
16%
Biological Function
16%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
16%
Label-free
16%
Proteome
16%
Atherosclerotic Lesions
16%
Vascular Disease
16%
Fc Fragment
16%
CD-1 Mice
16%
Disease Control
16%
Fisher's Exact Test
16%
High Protein
16%
Intensity Data
16%
Mass Spectrometry Data
16%
Tandem Mass Spectrometry
16%
Hematological Diseases
16%
Immunoglobulin G2
16%
Probability Value
16%
Disease Clusters
16%
Plasma Pool
16%
Disease Analysis
16%
Disorder Analysis
16%
Medicine and Dentistry
Pre-Eclampsia
100%
Protein Tyrosine Kinase
100%
Maternal Plasma
100%
Proteome
100%
Maternal Welfare
33%
Diseases
33%
Disease Predisposition
16%
Cardiovascular System
16%
Cardiovascular Disease
16%
Adenoviridae
16%
Atherosclerosis
16%
Serositis
16%
Vascular Disease
16%
Immunoglobulin Fc Fragment
16%
Biological Product
16%
Adverse Outcome
16%
Fisher Exact Test
16%
Nosology
16%
Liquid Chromatography-Mass Spectrometry
16%
Water-Electrolyte Imbalance
16%
Tandem Mass Spectrometry
16%
Disease
16%
Immunoglobulin G2
16%
Metabolic Disorder
16%
Pharmacology, Toxicology and Pharmaceutical Science
Protein Tyrosine Kinase
100%
Preeclampsia
100%
Proteome
100%
Diseases
50%
Adverse Outcome
16%
Atherosclerosis
16%
Inflammation
16%
Vascular Disease
16%
Disease Predisposition
16%
Biological Product
16%
Adenoviridae
16%
CD-1 Mouse
16%
Immunoglobulin Fc Fragment
16%
Immunoglobulin G2
16%
Hematologic Disease
16%
Disease Classification
16%
Cardiovascular Disease
16%
Metabolic Disorder
16%
Biochemistry, Genetics and Molecular Biology
Proteome
100%
Soluble Fms-Like Tyrosine Kinase-1
100%
Blood Plasma
100%
Animal Model
25%
Intravenous Immunoglobulin
25%
Liquid Chromatography-Mass Spectrometry
25%
Adenoviridae
25%
Metabolic Disorder
25%
Disease Classification
25%
Tandem Mass Spectrometry
25%
CD-1 Mouse
25%